Fedha

Hisa unazofuatilia
AUROPHARMA:NSE
Aurobindo Pharma Ltd
₹ 1,666.90
-0.66%
(-11.00) Siku 1
16 Okt, 15:30:00 GMT +5:30  ·   INR
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya AUROPHARMA...
Fungua
₹ 1,677.90
Juu
₹ 1,681.70
Chini
₹ 1,655.00
Mtaji wa soko
959.10B
Wastani wa kiasi cha mauzo
elfu 778.73
Kiasi cha mauzo ya hisa
elfu 796.73
Uwiano wa bei ya hisa na mapato kwa kila hisa
26.04
Juu kwa wiki 52
₹ 1,740.00
Chini kwa wiki 52
₹ 1,080.10
EPS
₹ 64.00
Hisa za wawekezaji
585.90M
Idadi ya wafanyakazi
elfu 29
Fungua
₹ 1,677.90
Juu
₹ 1,681.70
Chini
₹ 1,655.00
Mtaji wa soko
959.10B
Wastani wa kiasi cha mauzo
elfu 778.73
Kiasi cha mauzo ya hisa
elfu 796.73
Uwiano wa bei ya hisa na mapato kwa kila hisa
26.04
Juu kwa wiki 52
₹ 1,740.00
Chini kwa wiki 52
₹ 1,080.10
EPS
₹ 64.00
Hisa za wawekezaji
585.90M
Idadi ya wafanyakazi
elfu 29
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
Kuhusu Aurobindo Pharma Ltd
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 29.2
Lilianzishwa1986
Makao makuuHyderabad, Andhra Pradesh, India
Sekta-
Tovutiaurobindo.com
Ripoti ya mwisho
6 Ago 2026
Kipindi cha Kifedha
Robo1 2027
₹ 17.46 / ₹ 17.26
+1.17%umepitiliza
Mapato dhidi ya makadirio (INR)
91.50B / 89.98B
+1.69%umepitiliza
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 1 ya mwaka wa fedha wa 2027
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari
Maarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika INR
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika INR
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
82.86B
86.46B
88.53B
91.50B
Gharama ya bidhaa zilizouzwa
33.39B
34.81B
39.28B
36.27B
Gharama ya mapato
33.39B
34.81B
39.28B
36.27B
Gharama za utafiti na maendeleo
-
-
-
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
12.77B
13.10B
14.31B
14.80B
Gharama ya uendeshaji
36.98B
38.56B
35.29B
41.29B
Jumla ya gharama za uendeshaji
70.37B
73.37B
74.57B
77.56B
Mapato ya uendeshaji
12.49B
13.09B
13.96B
13.94B
Mapato mengine yasiyo ya uendeshaji
1.16B
1.54B
-2.51B
2.12B
EBT ikijumuisha vipengee visivyo vya kawaida
12.76B
13.39B
12.91B
15.15B
EBT bila kujumuisha vipengee visivyo vya kawaida
12.76B
14.04B
13.59B
15.55B
Gharama ya kodi ya mapato
4.28B
4.29B
3.70B
4.83B
Kiwango cha kodi kinachotumika
33.53%
32.03%
28.65%
31.88%
Gharama nyingine za uendeshaji
19.91B
20.81B
16.37B
21.62B
Mapato halisi
8.48B
9.10B
9.21B
10.33B
Kiwango cha faida halisi
10.24%
10.53%
10.41%
11.28%
Mapato kwa kila hisa
14.61
16.43
15.86
17.46
Mapato ya riba na uwekezaji
-
-
3.31B
-
Gharama ya riba
-952.40M
-927.70M
-665.50M
-1.02B
Jumla ya gharama halisi za riba
-952.40M
-927.70M
2.65B
-1.02B
Gharama za kushuka kwa thamani na za kulipa deni
4.29B
4.65B
4.61B
4.87B
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
16.66B
16.71B
18.03B
18.01B
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho
Programu za Google